ARX:ASX
Aroa Biosurgery Ltd
0,48 A$
arrow_downward
-1,02%(-0,0050) 1D
20 նոյ, 16:10:08 GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
0,50 A$
High
0,50 A$
Low
0,48 A$
Mkt. cap
167,76 մլն
Avg. vol.
259,42 հզր
Volume
192,34 հզր
P/E ratio
46,19
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
Open
0,50 A$
High
0,50 A$
Low
0,48 A$
Mkt. cap
167,76 մլն
Avg. vol.
259,42 հզր
Volume
192,34 հզր
P/E ratio
46,19
52-wk high
0,78 A$
52-wk low
0,46 A$
EPS
0,01 A$
Shares outstanding
345,90 մլն
No. of employees
261
News stories
From web sources and news partners
The Motley Fool
·
3 ժամ առաջ
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
TradingKey
·
8 ժամ առաջ
S&P 500 Falls Below 200-Day Moving Average: Buy-the-Dip Opportunity or Bear Market Warning?
Beinsure
·
17 ժամ առաջ
Vanguard S&P 500 ETF: How investing in VOO could build a $1 mn portfolio
JournalArta
·
8 րոպե առաջ
S&P 500 Falls Into Correction as AI Stocks Slide
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd